Recurrent Isolated Neuroretinitis and Papillitis with Positive Glial Fibrillary Acidic Protein (GFAP) Autoantibody
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
We present the case of a patient with recurrent episodes of papillitis and neuroretinitis in both eyes, without any other CNS involvement, with positive GFAP-IgG in CSF. A 46-year-old male initially presented with subacute painless visual loss. Fundus examination showed disc oedema and macular exudation in right eye (OD) and he was treated with methylprednisolone with improvement of visual acuity (VA). Three weeks later, perimacular hard exudates appeared. Eighteen months later, the patient had a new episode of visual loss with optic disc and retinal edema in OS and was treated again with intravenous and oral corticosteroids. After a third episode nine months later, GFAP antibodies were detected in CSF and azathioprine was added. After further relapses, azathioprine was switched to mycophenolate mofetil and later to rituximab but his visual function was not recovered. In patients with glial autoimmune fibrillary acidic protein astrocytopathy (GFAP-A) visual involvement is frequently described but its presentation as an exclusive clinical manifestation is very unusual. In clinical cases of recurrent neuroretinitis and papillitis, which, despite aggressive treatment, can be very refractory to treatment and leave irreversible visual deficits, we propose the determination of GFAP antibodies in CSF to complete the diagnosis and improve treatment in these patients.
Fields of Study & Subjects
Ocular Diseases and Behçet’s Syndrome
Autoimmune Neurological Disorders and Treatments
Multiple Sclerosis Research Studies
Publication details
- Journal / source
- Neuro-Ophthalmology
- Pages
- 1–8
- Publication date
- 31 March 2026
- Language
- EN